Press release
Carbapenem-based Antibiotics Market to Exhibit 7% CAGR, with Sales of Tebipenem and Sulopenem Projected to Soar
Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. Broad-spectrum carbapenem-based antibiotics such as tebipenem (Spero Therapeutics Inc.) and sulopenem (Iterum Therapeutics Inc.) are at late stage clinical development with expected launch of both in 2020 - 2021.Multidrug resistance to currently marketed carbapenem-based antibiotics is largely prevalent in the world. Also, expiry of patent for ertapenem is expected to offer new avenues for market growth in regulated as well as non-regulated carbapenem-based antibiotics market where its adoption & availability are comparatively limited. On the back of these factors, the global carbapenem-based antibiotics market is estimated to reach a valuation of US$1.8 Bn by 2029.
Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4425
Key Takeaways of Carbapenem-based Antibiotics Market Study
• Larger patient pools and launch of novel products for the treatment of bacterial infections are expected to shape the carbapenem-based antibiotics market landscape.
• Increasing prevalence of bacterial infections caused by longer stay in hospitals as well as immunocompromising chronic diseases that make patients prone to bacterial infections is expected to boost carbapenem-based antibiotics market growth.
• Currently, the carbapenem-based antibiotics market is dominated by ertapenem. However, tebipenem is expected to gain traction during the forecast period in terms of revenue.
• In terms of indication, pneumonia is expected to garner highest market share as compared to other bacterial infections owing to a large patient pool.
For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4425
“ Recently, FDA granted Qualified Infectious Disease Product (QIDP) to sulopenem as well as tebipenem for new indications, which is further expected to broaden the growth prospect of the carbapenem-based antibiotics market," says the Fact.MR Analyst.
Strategic Expansion by Dominant Players Benefiting Market
The carbapenem-based antibiotics market is dominated by top three players including Merck Co. & Inc., Pfizer Inc., and Sumitomo Dainippon Pharma Co., Ltd. These leading players in the carbapenem-based antibiotics market contribute around 80% to 90% revenue share. Clinical stage companies such as Spero Therapeutic Inc. and Iterum Therapeutics Inc. with the launch of their novel carbapenem-based antibiotics are expected to acquire significant market space. In October 2017, Spero Therapeutics, Inc. and Meiji Seika Pharma Co., Ltd. announced an exclusive licensed partnership for its carbapenem-based antibiotic named SPR994 (tebipenem). In a similar development, Sumitomo Dainippon Pharma in June 2017, announced a partnership with Zuellig Pharma for sales of carbapenem-based antibiotic meropenem in five countries of Southeast Asia (Vietnam, Thailand, Singapore, Philippines, Malaysia) and Hong Kong.
Looking for more information?
The research study on carbapenem-based antibiotics market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends which have shaped the landscape of carbapenem-based antibiotics over 2014 - 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 - 2029. Market statistics have been presented on the basis of product type (Meropenem, imipenem, ertapenem, tebipenem, doripenem, panipenem, etc.), indication (intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, skin and skin structure infections, acute pelvic infections, prophylaxis of surgical site infection, respiratory tract infections, others), sales channel (hospital pharmacies, retail pharmacies, online pharmacies) across seven major regions.
Get Full Access of the Report @ https://www.factmr.com/checkout/4425/S
Fact.MR’s Domain Knowledge in Healthcare
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
E-mail: sales@factmr.com
Website : https://www.factmr.com
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carbapenem-based Antibiotics Market to Exhibit 7% CAGR, with Sales of Tebipenem and Sulopenem Projected to Soar here
News-ID: 2228953 • Views: …
More Releases from Fact.MR

Robot Arms Market is Anticipated to Reach US$ 77.2 Billion by 2033
According to Fact.MR, a market research and competitive intelligence provider, the global robot arms market is estimated to be valued at USD 26.2 billion in 2023 and is expected to expand at an impressive CAGR of 11.4% during the forecast period.
The use of robot arms is increasing across diverse industries such as manufacturing, healthcare, logistics, supply chain, and retail. With the growing integration of technologies like machine learning and artificial…

Mechanically Separated Poultry Market Is Projected To A Colossal $255.9 Million …
It is anticipated that the global mechanically separated poultry market would reach US$ 160.4 million by 2024. By the end of 2034, the mechanically separated poultry market is expected to grow at a 4.8% CAGR and be worth US$ 255.9 million worldwide. The mechanically separated poultry (MSP) market has seen consistent growth over recent years, driven by increasing demand for cost-effective meat products and advancements in food processing technologies. This…

Glucose Management Supplement Market Is Expected To A Colossal $17.5 Billion By …
The estimated worth of the global glucose management supplement market is expected to rise from US$ 9.7 billion in 2024 to US$ 17.5 billion by the end of 2034. It is true.Sales of glucose management supplements are expected to increase at a compound annual growth rate (CAGR) of 6.1% between 2024 and 2034, according to MR's most recent analysis.
The glucose management supplement market has seen significant growth in recent years,…

Rosehip Market Is Expanding Estimated To A Colossal $486.7 Million By 2034
The revenue from the global rosehip market is expected to grow at a 5.6% CAGR from 2024 to 2034, from a value of US$ 282.6 million in 2024 to US$ 486.7 million by the end of that year. The Rosaceae family includes the herbal medicine made from rosehips. This wild rose variety, also called Rosa canina, grows well in many parts of Asia, Africa, and Europe. After fertilization, rosehips, the…
More Releases for Antibiotics
Cephalosporin Antibiotics API market: Key Tactics by Players to Consolidate Pres …
"
The Cephalosporin Antibiotics API global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key…
Cephalosporin Antibiotics API Market to Witness Huge Growth by Key Players: NCPC …
The Cephalosporin Antibiotics API report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Cephalosporin Antibiotics API research report recognizes and…
Antibiotics Market Excellent Growth 2021 Top Key Players | Antibiotics market a …
Antibiotics Market Overview:
The market research report on the Global Antibiotics Market offered by Straits Research, analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of the Global Antibiotics Market. The competition landscape, company overview, financials, recent developments and long-term investments related to the Global Antibiotics Market are mentioned in this report. Various parameters have been studied while estimating the market size. The revenue…
Global Antibiotics Market Overview 2019-2025
The global antibiotics market is expected to reach USD 40.78 billion by 2025. Increasing prevalence of infectious diseases worldwide is a major factor driving the global antibiotics market. Since the discovery of antibiotics in the early 20th century, these have been an essential tool in treating the massive burden of infectious diseases worldwide. Yet antimicrobial resistance or AMR is increasingly threatening the effectiveness of antibiotics, which may restrain their use.
Major…
Macrolide Antibiotics Market Greater Revenue Share by 2026(Macrolide Antibiotics …
Macrolide Antibiotics are bacteriostatic in nature with a broad spectrum of activity against many gram-positive bacteria. Macrolide Antibiotics are primarily useful in treating soft tissue, respiratory condition, sexually transmitted and atypical mycobacterial infections. Macrolide Antibiotics also possess anti-inflammatory and immunomodulatory effects which are used for certain health conditions. Macrolide Antibiotics are considered to be both first line and second line of treatment, it mainly depends on the conditions it is…
Global MRSA Antibiotics Market: Scenario 2025
“Global MRSA Antibiotics Industry Report" is an expert and in-depth analysis of key business and future development prospects, key determinants and restrictions, profiles of major market players, segmentation and forecasting. The study offers a comprehensive qualitative analysis of the industry's growth parameters, the current state of the market in terms of analysis of key economic situations and macroeconomic analysis. The analysis highlights the growth opportunities of key market segments along…